Pediatric intensive care unit

Tobias JD Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 28 2122-2132, 2000... 

A pediatric nurse is found to be colonized with MRSA in her nares during an outbreak investigation in the pediatric intensive care unit. The best strategies to eradicate her nasal carriage could be... 

Bakshi F, Barzilay Z, Paret G. Adenosine in the diagnosis and treatment of narrow complex tachycardia in the pediatric intensive care unit. Heart Lung 1998 27(l) 47-50. 

There was an unexpectedly high frequency of adverse effects in a pediatric intensive care unit with the combination of high-dose phenobarbital and beta-lactam antibiotics, mainly cefotaxime (353). The reactions, which mostly affected the skin and blood, were only rarely reproduced by a single component, suggesting an interaction. However, these findings have not been confirmed, and their impact is unclear. 

George R, Stevens A, Berkenbosch JW, Turpin J, Tobias J. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients. South Med J 2002 95(ll) 1276-9. 

Cimino M A, Kirschbaum MS, Brodsky L, Shaba S H (2004). Assessing medication prescribing errors in pediatric intensive care units. Pediatr Crit Care Med 5 124-132. 

Schneider M-P, Cotting J, Pannatier A (1998). Evaluation of nurses errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci 20 178-182. 

After ten days in the pediatric intensive care unit, Josie was healing well enough to be sent to an intermediate care unit. The family was told that she could be sent home within days, and the child s older siblings began preparing a celebration to welcome their sister home. 

Josie s heart stopped. As medical staff worked on the child, her mother was taken to a room where she was met by a chaplain. Two days later, back in the pediatric intensive care unit, Josie s life support was removed. 

Transplant clinic and all operating rooms Delivery rooms and catheter labs Cancer clinics and infusion rooms Bone marrow transplant unit (adult and pediatric) Intensive care units and dialysis units Oncology clinics and transplant units Central supply and sterile processing areas Nursery and neonatal units Food preparation/service areas... 

The safety and efficacy of nalbuphine, with respect to the treatment of pediatric pain, have not been fully established. For patients older than 1 year of age, doses of 0.1-0.2 mg/kg SQ/IM/IV every 3-4 hours are utilized, and individualized, as above [6]. The maximum dose is 20 mg/administration and the daily total dose should not exceed 160 mg. Nalbuphine, in doses of 0.05-0.1 mg/kg SQ/IM/IV, has been used to facilitate weaning from mechanical ventilation in the pediatric intensive care unit setting. Nalbuphine is also used to relieve pruritus, caused by narcotic administration, in this population as well as in adults. 

Bienert A, Bartkowska-Sniatkowska A, WiczUng P. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children. Pharmacol Rep 2013 65(1) 107-21. 

KruesseU MA, Udink ten Cate FE, Kraus AJ, Roth B, Trieschmann U. Use of propofol in pediatric intensive care units a national survey in Germany. Pediatr Crit Care Med 2012 13 el50-154. 

Carroll TG, Dimas VV, Raymond TT. Vasopressin rescue for in-pediatric intensive care unit cardiopulmonary arrest refractory to initial epinephrine dosing a prospective feasibility pilot trial. Pediatr Crit Care Med 2012 13(3) 265-72. Epub 2011/09/20. 

Neonatal and Pediatric Intensive Care Unit Patients... 

In general, the rate of nosocomial infections, including nosocomial respiratory tract infections, varies inversely with age. Hospital-wide nosocomial infection rates (of all types) have been reported as 11.5% for children 23 months of age and younger, 3.6% for children 2 to 4 years of age, and 2.6% for children at least 5 years old (26). Within a pediatric intensive care unit (PICU), nosocomial infection rates were two to three times higher for children 1 month of age or younger compared with children who were at least 2 years old at the time of hospitalization (3). 

Nosocomial lower respiratory tract infections may occur in children hospitalized in any area of a hospital. However, the children at greatest risk for nosocomial pneumonia and tracheitis are those cared for in an intensive care setting these account for >50% of all nosocomial pneumonias (28). Nosocomial lower respiratory tract infection will develop in approximately 2% to 10% of children in a pediatric intensive care unit. Similar but slightly lower proportions apply in infants cared for in neonatal intensive care units. 

A recent study performed in a Canadian pediatric intensive care unit identified specific risk factors or markers associated with bacterial nosocomial pneumonia and bacterial nosocomial tracheitis (38). By multivariate analysis, the following risk factors or markers (with odds ratio) were significantly associated with nosocomial infection ... 

Milliken J, Tait CA, Mindorff CM, Ford-Jones EL, Gold R, Mullins G. Nosocomial infections in a pediatric intensive care unit. Crit Care Med 1988 16 233-237. 

John M, Tucci M, Lacroix J, Farrell CA, Gauthier M, Lafleur L, Nadeau D. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit. Am J Respir Crit Care Med 1997 155 162-169. 

Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991 91 (suppl 3B) 185S-191S. 

E. V. Pedapati and S. T. Bateman, Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/ naloxone, Pediatr. Crit. Care Med., 2011, 12, el02-el07. 

---